Davita Clinical Research

Lakewood, Colorado 80228

0 studies enrolling now · 23 studies all time

What they study most

Acinetobacter Baumannii Infection, Antithrombotic, Blood Loss, Chronic-kidney Disease Stage 5D on Stable Hemodialysis, Cystic Fibrosis, End Stage Renal Disease, Fluid Retention Tissue, Healthy, Healthy Volunteers, Hepatic Impairment, Hepatic Insufficiency, Hyperphosphatemia

Studies at this site

• A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects — Completed
• Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw — Completed
• A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis — Completed
• Measuring Thoracic Impedance in Hemodialysis Patients With the u-Cor Monitoring System — Completed
• A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment. — Completed
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105 — Completed
• DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis — Completed
• A Study of Abemaciclib in Participants With Varying Degrees of Liver Impairment — Completed
• Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects — Completed
• Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Seladelpar in Subjects With Hepatic Impairment and Healthy Subjects — Completed
• A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment — Completed
• Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting — Completed
• The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency — Completed
• CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes — Completed
• CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes — Completed
• CSD1602: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From Two King Size Menthol Cigarette Products — Completed
• CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products — Completed
• MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Cavosonstat (N91115) in Healthy Subjects (SNO-9) — Completed
• Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer — Completed
• MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects — Completed
• Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in Combination — Completed
• A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan — Completed
• Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency — Completed